| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/23/2008 | EP1272514B1 Dna encoding human vanilloid receptor vr3 |
| 01/23/2008 | EP1240310B1 Method of inactivating microorganisms |
| 01/23/2008 | EP1220925B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/23/2008 | EP1210372B1 Human monoclonal antibodies to her2/neu |
| 01/23/2008 | EP1194445B1 Methods for purifying recombinant growth hormone antagonist proteins using aqueous two-phase extraction |
| 01/23/2008 | EP1175444B1 Amino-terminal modified parathyroid hormone (pth) analogs |
| 01/23/2008 | EP1140998B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/23/2008 | EP1135498B1 Antibody variants with higher binding affinity compared to parent antibodies |
| 01/23/2008 | EP0804558B1 Tripeptidyl aminopeptidase |
| 01/23/2008 | CN101111599A Expression carrier used for treating bacterial infection |
| 01/23/2008 | CN101109012A Representation of vampire plasmin activator alpha 2 in yeast and manufacturing method thereof |
| 01/23/2008 | CN101108196A Method of producing glossy ganoderma polypeptide product |
| 01/23/2008 | CN100363500C Preparation method of recombination human granular cell colony stimulating factor |
| 01/23/2008 | CN100363485C Fermentation method of engineering bacteria for preparing recombination human granular cell colony stimulation factor |
| 01/23/2008 | CN100363484C Hebei Amycolatopsis hebeiensis bacterial strain and preparation Norvancomycin fermented by the strain |
| 01/22/2008 | US7321028 Comprises leucine rich repeat domains; kits; drug screening; for treating apoptosis |
| 01/22/2008 | US7321026 Framework-patched immunoglobulins |
| 01/22/2008 | US7321024 Produced by a Paenibacillus polymyxa strain, used for reducing the levels of colonization by a target bacteria in animals, especially poultry. |
| 01/22/2008 | US7320892 Nucleotide sequences involved in plant disease resistance |
| 01/22/2008 | US7320887 Alkaline protease variants |
| 01/22/2008 | US7320880 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and DNA coding for the same |
| 01/22/2008 | US7320875 Screening for neutralizing hepatitis C virus antibodies in a blood sample utilizing an HCV E2 protein and a protein from a human or chimpanzee cell that has a molecular weight of 24 kd that binds to the E2 protein of HCV; comparing the amount of bound proteins to that in the absence of HCV antibodies |
| 01/22/2008 | US7320863 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 01/22/2008 | US7320794 Membrane permeability of a substrate, hydantoin-transporter activity |
| 01/22/2008 | US7320791 Monoclonal antibody for analysis and clearance of polyethylene glycol and polyethylene glycol-modified molecules |
| 01/22/2008 | US7320790 Humanized antibodies |
| 01/22/2008 | US7320789 Antibody inhibitors of GDF-8 and uses thereof |
| 01/22/2008 | US7320787 Genetic engineering; desroying infections; antitumor, anticancer agents |
| 01/22/2008 | CA2436779C Human mitochondrial proteins and polynucleotides encoding the proteins |
| 01/22/2008 | CA2423887C Recombinant terminal deoxynucleotidyl transferase with improved functionality |
| 01/22/2008 | CA2380569C Chimeric polypeptides, method for production and uses thereof |
| 01/22/2008 | CA2365237C Method for synthesis of polypeptides in cell-free systems |
| 01/22/2008 | CA2289914C Igf-1 receptor interacting proteins (iips), genes coding therefor and uses thereof |
| 01/22/2008 | CA2201730C The use of homologous amds genes as selectable markers |
| 01/22/2008 | CA2185516C Homogeneous gene probe test using a receptor directed against the label |
| 01/22/2008 | CA2128602C Synthetic eukaryotic promoters containing two inducible elements |
| 01/17/2008 | WO2008007804A1 ANTIHUMAN α9 INTEGRIN ANTIBODY AND USE OF THE SAME |
| 01/17/2008 | WO2008007755A1 Cell death inducer |
| 01/17/2008 | WO2008006927A1 Peptide and nucleotide sequences of anisakis spp., antibodies that recognise said sequences and uses of same |
| 01/17/2008 | WO2008006497A1 Method for producing insulin analogs having a dibasic b chain terminus |
| 01/17/2008 | WO2007130875A3 Microwave assisted deglycosylation of proteins for molecular weight determination by mass spectrometry |
| 01/17/2008 | WO2005021710A3 Chimeric molecules and methods of use |
| 01/17/2008 | WO2003004615A3 Secreted proteins |
| 01/17/2008 | WO2002066670A3 46798, a human matrix metalloproteinase and uses therefor |
| 01/17/2008 | US20080016584 phytases belong to the acid histidine phosphatase family, are acid-stable, and expectedly of a high specific activity; animal feed |
| 01/17/2008 | US20080015347 Kind Of Fusion Protein, Gene Encoding It, Expression Method And Use Thereof |
| 01/17/2008 | US20080015338 Individualized anti-cancer antibodies |
| 01/17/2008 | US20080015337 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof |
| 01/17/2008 | US20080015165 Novel polypeptide |
| 01/17/2008 | US20080015164 Methods and compositions for inactivation of dihydrofolate reductase |
| 01/17/2008 | US20080015153 Pharmaceutical compositions containing the long pentraxin PTX3 |
| 01/17/2008 | US20080015152 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive, eating and nervous system disorders |
| 01/17/2008 | US20080015149 Galectin 11 |
| 01/17/2008 | US20080014635 Methods of increasing protein expression levels |
| 01/17/2008 | US20080014614 Labeling of rapamycin using rapamycin-specific methylases |
| 01/17/2008 | US20080014613 Prokaryotic collagen-like proteins and uses thereof |
| 01/17/2008 | US20080014612 Method for producing glucose dehydrogenase from aspergillus oryzae |
| 01/17/2008 | US20080014611 Method for highly expressing recombinant glucose dehydrogenase derived from filamentous bacterium |
| 01/17/2008 | US20080014609 Methods for Obtaining Thermostable Enzymes, Dna Polymerase I Variants from Thermus Aquaticus Having New Catalytic Activities, Methods for Obtaining the Same, and Applications to the Same |
| 01/17/2008 | US20080014608 Modified Promoter |
| 01/17/2008 | US20080014215 Animal Bioreactors |
| 01/17/2008 | US20080014210 Peptides and antibodies to muc 1 proteins |
| 01/17/2008 | US20080014208 Fusion proteins, uses thereof and processes for producing same |
| 01/17/2008 | US20080014197 Neutralizing human anti-igfr antibody |
| 01/17/2008 | US20080014195 Antagonists Of Myelin-Associated Glycoprotein And Their Use In The Treatment And/Or Prevention Of Neurological Diseases |
| 01/17/2008 | US20080014188 Manufacture of Highly Phosphorylated Lysosomal Enzymes and Uses Thereof |
| 01/17/2008 | DE19907485B4 Virus-Vakzine Virus vaccine |
| 01/17/2008 | CA2657133A1 Anti-human .alpha.9 integrin antibody and use of the same |
| 01/17/2008 | CA2657041A1 Method for producing insulin analogs having a dibasic b chain terminus |
| 01/16/2008 | EP1878746A2 Human monoclonal antibodies to epidermal growth factor receptor |
| 01/16/2008 | EP1878441A2 Complement pathway inhibitors binding to C5 and C5a without preventing the formation of C5b |
| 01/16/2008 | EP1877580A2 Lawsonia intracellularis immunological proteins |
| 01/16/2008 | EP1877537A2 Wood-rotting basidiomycetes for production of ligninolytic enzymes |
| 01/16/2008 | EP1877425A2 Fluorescent proteins and uses thereof |
| 01/16/2008 | EP1877421A2 Single-chain antibody with cleavable linker |
| 01/16/2008 | EP1877420A1 Combination therapy in the treatment of cancer |
| 01/16/2008 | EP1877090A2 Trimeric ox40-immunoglobulin fusion protein and methods of use |
| 01/16/2008 | EP1877083A2 Antibodies for the treatment of cancers |
| 01/16/2008 | EP1877030A2 Duffy antigen receptor for chemokines and use thereof |
| 01/16/2008 | EP1326894B1 Novel tumor-associated marker |
| 01/16/2008 | EP1019073B1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 01/16/2008 | EP0991761B1 Novel mutants of gram negative mucosal bacteria and application thereof in vaccines |
| 01/16/2008 | EP0898577B1 STREPTOCOCCUS PNEUMONIAE METHIONYL tRNA SYNTHETASE |
| 01/16/2008 | EP0837927B1 Anti-cd80 antibodies |
| 01/16/2008 | EP0795014B1 Costimulatory T cell surface antigen SLAM |
| 01/16/2008 | CN101107360A HCV F protein and uses thereof |
| 01/16/2008 | CN101104866A Technique for producing protein peptide and isoflavone extracted from bean sprout |
| 01/16/2008 | CN101104637A Cecropin and its generation bacterial strain and use |
| 01/16/2008 | CN101104542A Method for treating monosodium glutamate waste water by concentration biochemical process |
| 01/16/2008 | CN100362109C Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester |
| 01/16/2008 | CN100362105C Production of pancreatic procarboxy-peptidease B, isoforms and nuteins thereof, and their use |
| 01/15/2008 | US7319144 Polynucleotides encoding a multiple epitope fusion antigen for use in an HCV antigen/antibody combination assay |
| 01/15/2008 | US7319143 Genetically-engineered MHC molecules |
| 01/15/2008 | US7319140 Binding compounds to DAP12 proteins |
| 01/15/2008 | US7319139 TAG-72 specific CH2 domain deleted antibodies |
| 01/15/2008 | US7319136 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 01/15/2008 | US7319135 PRO1341 polypeptides |
| 01/15/2008 | US7319134 Polypeptide having a modified amino acid sequence of a fragment of nuclear factor-interleukin 6/lymphokine activating protein; activateS various target genes, such as cytokine genes; regulation of gene expression; antiproliferative agents |
| 01/15/2008 | US7319030 Bacillus deletion mutant for use as bioreactor in the expression of heterologous nucleotide sequences |
| 01/15/2008 | US7319027 Contacting chiral primary amine, omega-transaminase, and amino acceptor to convert into ketone; stereospecific; gene expression; can be used to enrich enantiomerically a mixture of chiral amines or to synthesize stereoselectively one of a pair of chiral amines |